Research & development > Clinical diagnostics

Prostate cancer urine test indicates disease aggression

28 April, 2021

An experimental new urine test for prostate cancer has the potential to revolutionise how patients with suspected prostate cancer are risk-assessed prior to an invasive biopsy.


Assay enables fast diagnosis of liposarcomas

11 February, 2021

Researchers have developed a gene panel test that allows for highly accurate diagnosis of the most common types of liposarcoma.


Aus biotech company supplies at-home COVID-19 tests to US

03 February, 2021 by Lauren Davis

Queensland-based company Ellume has announced a US$231.8 million (AU$302.7 million) agreement to accelerate domestic US production of its COVID-19 home tests.


Biomarker helps to diagnose Alzheimer's early

15 December, 2020

Researchers have found new forms of tau protein that become abnormal in the very early stages of Alzheimer's disease before cognitive problems develop.


Biomarker blood test could diagnose HPV-related cancers

20 November, 2020

Neck, head and anal cancers linked to human papilloma viruses (HPV) could be detected early, thanks to a highly specific diagnostic test.


Saliva testing may help doctors diagnose concussions

17 November, 2020

Doctors may be able to more accurately confirm concussions by measuring mRNA in a person's saliva, aiding diagnosis in a non-invasive, non-biased fashion.


Rapid diagnostic could save people from dying of blood loss

12 November, 2020

A diagnostic made from a glass slide, Teflon film and a piece of paper can test for levels of fibrinogen concentration in blood in less than four minutes.


New blood test predicts severity of COVID-19 infections

05 November, 2020

The Dublin-Boston score is claimed to accurately predict how severe infection will be on day seven after measuring the patient's blood for the first four days.


Cancer cells traced back to their tumour of origin

02 November, 2020

Researchers have traced cancer cells back to their tumour of origin by detecting an overexpression of fibroblast growth factor receptor in both the cancer cells and the tumour.


6 min Strep A test suitable for remote settings

10 September, 2020

Rapid, molecular point-of-care tests can be used in remote settings to accurately detect the presence of Strep A bacterium in just six minutes.


20 min assay for COVID-19 developed

20 August, 2020

The rapid molecular test, called N1-STOP-LAMP, involves using a small portable machine that can detect SARS-CoV-2 from just one nasal swab.


Non-fasting blood test can screen youth for prediabetes

12 August, 2020

The HbA1c test measures the degree to which sugar molecules have linked irreversibly to molecules in red blood cells in the previous few months.


Tau protein could be key to an Alzheimer's blood test

03 August, 2020 by Lauren Davis

Blood tests based on the tau protein phospho-tau217 (p-tau217) may be able to detect changes in the brain 20 years before dementia symptoms occur.


Radiation sickness detected in a drop of blood

28 July, 2020

The new test uses a single drop of blood — collected from a simple finger prick — and results are ready in a few hours.


New liquid biopsy method detects early kidney cancer

29 June, 2020

The method has been found to detect kidney cancers with high accuracy, including small, localised tumours for which no early detection method currently exists.


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd